Novartis AG Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 30, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	240,109	189,022	187,424	181,945	173,228	175,801
Market Cap Growth	25.44%	0.85%	3.01%	5.03%	-1.46%	-8.19%
Enterprise Value	259,936	205,618	199,660	191,485	196,976	199,153
Last Close Price	122.00	89.45	83.14	76.85	69.15	66.13
PE Ratio	19.57	16.39	13.95	27.96	8.20	26.64
PS Ratio	5.00	3.78	4.44	4.47	4.48	4.31
PB Ratio	6.30	4.43	4.43	3.27	2.91	3.80
P/TBV Ratio	-	-	-	69.00	21.01	-
P/FCF Ratio	14.39	12.04	15.46	14.60	14.07	17.38
P/OCF Ratio	13.37	11.11	14.33	13.66	13.07	15.75
EV/Sales Ratio	5.30	4.12	4.73	4.71	5.09	4.88
EV/EBITDA Ratio	11.86	10.30	12.60	14.68	14.33	16.32
EV/EBIT Ratio	14.61	13.04	17.46	22.21	20.43	24.00
EV/FCF Ratio	15.58	13.10	16.47	15.36	16.00	19.69
Debt / Equity Ratio	0.72	0.71	0.57	0.47	0.46	0.67
Debt / EBITDA Ratio	1.27	1.50	1.49	1.97	1.95	2.49
Debt / FCF Ratio	1.64	1.93	1.97	2.10	2.22	3.08
Asset Turnover	0.54	0.51	0.43	0.35	0.34	0.41
Inventory Turnover	2.17	2.20	1.84	1.67	1.65	2.31
Quick Ratio	0.58	0.79	0.88	1.00	1.25	0.65
Current Ratio	0.88	1.03	1.16	1.29	1.51	0.90
Return on Equity (ROE)	32.62%	26.27%	16.15%	9.51%	36.80%	14.38%
Return on Assets (ROA)	12.13%	10.09%	7.27%	4.62%	5.28%	5.16%
Return on Invested Capital (ROIC)	26.53%	23.55%	18.59%	11.14%	13.29%	10.58%
Return on Capital Employed (ROCE)	27.20%	22.20%	17.20%	10.40%	10.80%	10.70%
Earnings Yield	5.11%	6.10%	7.17%	3.58%	12.19%	3.75%
FCF Yield	6.95%	8.30%	6.47%	6.85%	7.11%	5.75%
Dividend Yield	2.56%	4.17%	4.26%	4.21%	4.32%	4.19%
Payout Ratio	54.32%	63.85%	48.85%	107.92%	30.67%	86.56%
Buyback Yield / Dilution	3.84%	2.73%	4.78%	2.79%	1.57%	0.99%
Total Shareholder Return	6.40%	6.89%	9.04%	7.00%	5.89%	5.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.